Clinical Trial Update: Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing Phase 1/2 results on intravitreal aflibercept injections and their effect on capillary non-perfusion in central retinal vein …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Proliferative Diabetic Retinopathy

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Ophthalmic Consultants of Boston | Conditions: Central Retinal Vein Occlusion, Proliferative Diabetic Retinopathy | Phase 1, Phase 2 | Status: COMPLETED